Market Cap

Adaptimmune Therapeutics plc Market Capitalization:

$199.9 Million

USD as of Jan. 1, 2024

business Adaptimmune Therapeutics plc Company Profile

Adaptimmune Therapeutics plc Main Stock Listing

NASDAQ: ADAP

Market Capitalization History of Adaptimmune Therapeutics plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Adaptimmune Therapeutics plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 $199.9 M -34.76%
Jan. 1, 2023 $306.4 M -40.07%
Jan. 1, 2022 $511.2 M -46.52%
Jan. 1, 2021 $955.8 M 40.00%
Jan. 1, 2020 $682.7 M -19.92%
Jan. 1, 2019 $852.6 M -43.57%
Jan. 1, 2018 $1.51 B 100.23%
Jan. 1, 2017 $754.5 M -39.04%
Jan. 1, 2016 $1.24 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Adaptimmune Therapeutics plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Adaptimmune Therapeutics plc has the following listings and related stock indices.


Stock: NASDAQ: ADAP

Stock: FSX: 473A

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.